John W. Cramer
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- DNA and Nucleic Acid Chemistry 3
- DNA Repair Mechanisms 1
- Oncology 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- James A. Miller (3 shared papers)Elizabeth C. Miller (3 shared papers)H. Steenbock (6 shared papers)Norman Morris (3 shared papers)William H. Prusoff (3 shared papers)Arnold D. Welch (3 shared papers)Vincent J. Pileggi (2 shared papers)Hector F. De Luca (1 shared paper)
- Journals
- Biochemical Pharmacology (4 papers)Archives of Biochemistry and Biophysics (4 papers)Journal of Biological Chemistry (2 papers)Experimental Cell Research (2 papers)Experimental Biology and Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
John W. Cramer
16 papers receiving 541 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 119
- Biochemistry 95
- Cancer Research 164
- Pharmaceutical Science 60
- Molecular Biology 327
Countries citing papers authored by John W. Cramer
This map shows the geographic impact of John W. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Cramer more than expected).
Fields of papers citing papers by John W. Cramer
This network shows the impact of papers produced by John W. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Cramer. The network helps show where John W. Cramer may publish in the future.
Co-authors
The 23 scholars most cited alongside John W. Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1960 | 240 | |
| 2 | The N- and ringhydroxylation of 2-acetylaminofluorene during carcinogenesis in the rat. | 1960 | 175 |
| 3 | 1960 | 76 | |
| 4 | 1956 | 30 | |
| 5 | 1962 | 28 | |
| 6 | 1967 | 22 | |
| 7 | 1956 | 15 | |
| 8 | 1961 | 14 | |
| 9 | 1954 | 14 | |
| 10 | 1973 | 10 | |
| 11 | 2003 | 8 | |
| 12 | 1968 | 8 | |
| 13 | 1961 | 8 | |
| 14 | Calcium metabolism and growth in the rat on a lowphosphorus diet as affected by vitamin D and increases in calcium intake. | 1956 | 4 |
| 15 | 1966 | 3 | |
| 16 | 1956 | 2 | |
| 17 | 1967 | 2 | |
| 18 | 1961 | 1 |
About John W. Cramer
John W. Cramer is a scholar working on Molecular Biology, Oncology, Physiology, Pathology and Forensic Medicine and Pharmacology, having authored 18 papers that have together received 660 indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (3 papers), Diet and metabolism studies (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Vitamin D Research Studies (2 papers), DNA Repair Mechanisms (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pharmacology (119 citations), Biochemistry (95 citations), Cancer Research (164 citations), Pharmaceutical Science (60 citations) and Molecular Biology (327 citations). John W. Cramer has collaborated with scholars based in United States. Frequent co-authors include James A. Miller, Elizabeth C. Miller, H. Steenbock, Norman Morris, William H. Prusoff, Arnold D. Welch, Vincent J. Pileggi, Hector F. De Luca, Pauline Chang and Alan C. Sartorelli. Their work appears in journals such as Biochemical Pharmacology, Archives of Biochemistry and Biophysics, Journal of Biological Chemistry, Experimental Cell Research and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.